Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information
This activity will review the latest PK recommendations for Factor VIII and IX replacement and how to use and interpret PK parameters to assess treatment plans.
Choose from the criteria below to find an activity that fits you best.
|A product of the Society of Infectious Diseases Pharmacists Education Center (SIDPEC)|
This CE activity is recommended for those interested in starting to measure their
antibiotic stewardship program and those interested in refining their current measuring
plan, specifically focusing on the inpatient setting. An overview of the types of
metrics for stewardship will be provided. A step-by-step guide to collecting, analyzing,
and utilizing data will be presented with anecdotal tips specific to antibiotic stewardship.
Lastly, different approaches to displaying antibiotic use data will be described and
the Centers for Disease Control and Prevention National Healthcare Safety Network
Antibiotic Use and Resistance Option will be explained, with an example of how this
data has been utilized in dashboard form within an integrated healthcare network.
This is a featured CE activity on the Society of Infectious Diseases Pharmacists Education Center (SIDPEC) website. SIDPEC is the educational hub of the Society of Infectious Diseases Pharmacists (SIDP). The SIDPEC portal provides educational activities on infectious disease pharmacotherapy for clinical pharmacists, health‐systems pharmacists, community pharmacists, and other allied‐health disciplines.
At the conclusion of this activity, participants should be able to:
Whitney R. Buckel, PharmD, BCPS-AQ ID
Infectious Diseases and Antimicrobial Stewardship Advanced Clinical Pharmacist
Intermountain Medical Center
No commercial funding was received for this activity.
Release Date: 7-21-2017
Expiration Date: 7-21-2020
This CE activity is jointly provided by ProCE, Inc. and SIDP. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-17-170-H04-P has been assigned to this knowledge-based home-study CE activity (initial release date 7-21-2017). This CE activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. CE credit will be uploaded to NABP/CPE Monitor. No partial credit will be given.
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and
scientific rigor in all of its continuing education activities. Faculty must disclose
to participants any significant financial interest or affiliation with companies that
manufacture or market products discussed in this activity. Dr. Buckel has received
honorarium from Merck for being a member of the Society for Healthcare Epidemiology
of America (SHEA) Antibiotic Research Workshop Planning Committee.
Please note: The information and views presented in this activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications, which should be considered experimental. Participants are advised to consult manufacturer product information and the professional literature, and use professional judgment in applying the presented information in patient-care activities.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.